Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TICAR

TICARCILLIN DISODIUM

Standard Dose
EQ 3GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TICAR is listed in Drugs@FDA under application 062690 (ANDA).

Marketing status: Discontinued Active ingredient TICARCILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 3GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1996-07-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview TICAR is listed in Drugs@FDA under application 062690 (ANDA). Marketing status: Discontinued Active ingredient TICARCILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 3GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1996-07-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TICAR (TICARCILLIN DISODIUM) | Drug Monograph | MedicHelpline